Live Breaking News & Updates on Utah Huntsman Cancer Institute

Stay updated with breaking news from Utah huntsman cancer institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Shifting Therapies to Earlier Settings Could Bolster Treatment Options in mHSPC and Oligometastatic Prostate Cancer

Neeraj Agarwal, MD, FASCO, discusses unmet needs across the prostate cancer spectrum and ongoing trials investigating agents in earlier settings. ....

United States , Neeraj Agarwal , Cancer Research , Genitourinary Oncology Program , Cancer Conference , Presidential Endowed Chair , Investigational Therapeutics , Utah Huntsman Cancer Institute , Salt Lake ,

Father fights for life after cancer diagnosis, advocates for genetic testing

A Clearfield man was given a fatal cancer diagnosis nearly a year ago \u2014 though, he s been able to stave off death due to treatment for a rare disease discovered earlier by genetic testing. ....

United States , Arianne Brown , Chris Bryant , Sara Bryant Hart , Phillip Bryant , Huntsman Cancer Institute Farmington , University Of Utah Huntsman Cancer Institute , Huntsman Cancer Institute , Utah Huntsman Cancer Institute ,

Kitco and Patel Emphasize the Importance of GVHD Research and Awareness

Drs Kitko and Patel discuss graft-versus-host disease recognition, treatment selection, and ongoing research with novel agents and biomarkers of response. ....

United States , Monroe Carell Jr , Carriel Kitko , Sagars Patel , Caroline Seymour , Pediatric Stem Cell Transplantation Program , Media Relationships For The Division Of Hematology , Live On Air , Ingram Professor , Pediatric Oncology , Monroe Carell , Media Relationships , Utah Huntsman Cancer Institute , Salt Lake , Second Annual , Onclive On Air , Apple Podcasts , Google Podcasts , Amazon Music , Graft Versus Host Disease Recognition , Gvhd Day , Monroe Carell Jr Childrens Hospital At Vanderbilt , The University Of Utah Huntsman Cancer Institute ,

Dr Tantravahi on the Efficacy of Selinexor Plus Ruxolitinib in JAK Inhibitor–Naive Myelofibrosis

Srinivas K. Tantravahi, MBBS, MRCP, discusses the preliminary efficacy of selinexor in combination with ruxolitinib in patients with JAK inhibitor–naive myelofibrosis, as seen in the phase 1 XPORT-MF-034 trial. ....

United States , Srinivask Tantravahi , University Of Utah Huntsman Cancer Institute , Utah Huntsman Cancer Institute , Reviewing Research Efforts Seeking To Raise The Bar In Myelofibrosis , Onclive Tv , Phase 1 3 Xport Mf 034 Trial , Jak Inhibitor Naive ,